Emergent BioSolutions Inc. (EBS) — Dilution Risk Analysis

Current Snapshot

Emergent BioSolutions Inc. (EBS) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
51,273,336 Source
Public Float
49,380,751 Source
Float as % of Outstanding
96.3%

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 8-K 1, 4 8.

FormFiledAccession
xbrl 2026-06-30 xbrl-3879-xbrl_warrant
8-K 2026-04-17 0001367644-26-000038
4 2026-04-03 0001961994-26-000013
4 2026-03-06 0001196632-26-000011
4 2026-03-05 0001919170-26-000009
4 2026-03-05 0001196632-26-000009
4 2026-03-05 0001961994-26-000009
4 2026-03-05 0002043716-26-000005
4 2026-03-05 0001989644-26-000005
4 2026-03-05 0002044279-26-000003

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 5 months Source
Three-year share count growth -1.03% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 50/10) Source
Cash Runway
5 months Source
Share Count Growth (3-Year)
-1.03% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.